SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting. The study demonstrated that nimacimab was safe, well-tol ...

(TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, declared a dividend and announced that it will release its third quarter 2025 financial results before the market open on November 6, 2025. Dividend The Company's Board of Directors has authorized a dividend of $0.025 per Subordinate Voting Share and Multiple Voting Share, payable on October 21, 2025 to sharehol. TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. ("Dentalcorp†or the "Company†) ...

Goldmoney Inc. Announces Normal Course Issuer BidSeptember 19, 2025 7:00 AM EDT | Source: GoldMoney Inc.Tortola, British Virgin Islands--(Newsfile Corp. - September 19, 2025) - Goldmoney Inc. (TSX: XAU) (US: XAUMF) ("Goldmoney" or the "Company"), today announced acceptance by the Toronto Stock Exchange (the "TSX") of Goldmoney's Notice of Intention to make a normal course issuer bid (the "NCIB") to purchase for cancellation up to 777,262 common shares (the "Shares") of Goldmoney. The Shares re ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host a webcast to review data from the successful TETON-2 pivotal study evaluating the use of nebulized Tyvaso® (treprostinil) Inhalation Solution for the treatment of idiopathic pulmonary fibrosis (IPF) on Sunday, September 28, 2025, at 12:30 p.m. Eastern Time. During the webcast, Steven D. Nathan, M.D., Schar Chair, Advanced Lung Disease and Lung Tran. ...

There was no obvious factor dragging prices lower, although investors may have been taking the chance to lock in some profit. ...

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the European Commission (EC) and Swiss Agency for Therapeutic Products, Swissmedic, have approved EKTERLY® (sebetralstat), a novel, oral plasma kallikrein inhibitor, for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. EKTERLY is the first and only oral on-demand treatment for HAE in the European U. ...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Myeloid Leukemia were updated to include revumenib as a category 2A recommendation for relapsed or refractory (R/R) acute myeloid leukemia (AML) with an NPM1 mutation (mNPM1).1 The update was based on p ...

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to announce that the Ministry of Industrial Policy and Energy of Huelva, Andalusia has granted the Company exploration permits for the San Antonio and Terranova claims (collectively, the “New Properties”) (Figure 1). These New Properties add an additional 181 hectares to Emerita’s wholly owned Iberian Pyrite Belt holdings. The New Properties are adjacent to the Ib ...

退休收入构成分析 - 养老金年收入为19200美元 提供稳定的基础收入来源[3] - 401(k)和储蓄账户总额达830000美元 按4%规则首年可提取33200美元[4] - 养老金与账户提取合计年收入达52400美元 税后约48000美元[4] 社会保障金测算 - 假设62岁退休且最后年薪40000美元时 年社保收入范围未具体披露但使总收入达63740-74216美元[6] - 最后年薪70000美元时 62岁/67岁/70岁领取社保的年收入分别为11340美元/17064美元/21816美元[7] - 社保福利显著提升总收入水平 最高可使年收入增加21816美元[6][7] 综合财务规划 - 未计算社保前 月度可支配收入约4000美元[5] - 总退休收入需结合个人支出水平和社会保障金领取时点综合评估[2] - 建议通过专业财务顾问进行个性化退休规划[2][5]

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Samsung Electronics, in collaboration with Niio, unveils Code of Nature — an immersive, generative digital art installation designed for The Wall LED display in the lobby of its Germany office in Eschborn. This striking installation transforms the space into a living canvas, reflecting Samsung’s commitment to innovation, culture, and its local presence. Created by renowned digital artist Ronen Tanchum of Phenomena Labs and curated with Niio — the global platform ...